|
1
|
Kuhnt D, Becker A, Ganslandt O, Bauer M,
Buchfelder M and Nimsky C: Correlation of the extent of tumor
volume resection and patient survival in surgery of glioblastoma
multiforme with high-field intraoperative MRI guidance. Neuro
Oncol. 13:1339–1348. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mrugala MM: Advances and challenges in the
treatment of glioblastoma: a clinician's perspective. Discov Med.
15:221–230. 2013.PubMed/NCBI
|
|
3
|
Nieder C, Astner ST, Mehta MP, Grosu AL
and Molls M: Improvement, clinical course, and quality of life
after palliative radiotherapy for recurrent glioblastoma. Am J Clin
Oncol. 31:300–305. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shang C, Lu YM and Meng LR: MicroRNA-125b
down-regulation mediates endometrial cancer invasion by targeting
ERBB2. Med Sci Monit. 18:BR149–BR155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang H, Guo Y, Shang C, Song Y and Wu B:
MiR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
Urology. 80:1298–1302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G,
Fu S, Zhang Y, Feng K and Feng Y: MicroRNA-128 plays a critical
role in human non-small cell lung cancer tumourigenesis,
angiogenesis and lymphangiogenesis by directly targeting vascular
endothelial growth factor-C. Eur J Cancer. 50:2336–2350. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin L, Chen X, Peng X, Zhou J, Kung HF,
Lin MC and Jiang S: microRNA-128 promotes cell-cell adhesion in U87
glioma cells via regulation of EphB2. Oncol Rep. 30:1239–1248.
2013.PubMed/NCBI
|
|
8
|
Shi ZM, Wang J, Yan Z, You YP, Li CY, Qian
X, Yin Y, Zhao P, Wang YY, Wang XF, et al: MiR-128 inhibits tumor
growth and angiogenesis by targeting p70S6K1. PLoS One.
7:e327092012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Adlakha YK and Saini N: MicroRNA-128
downregulates Bax and induces apoptosis in human embryonic kidney
cells. Cell Mol Life Sci. 68:1415–1428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li M, Fu W, Wo L, Shu X, Liu F and Li C:
MiR-128 and its target genes in tumorigenesis and metastasis. Exp
Cell Res. 319:3059–3064. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shang C, Zhang H, Guo Y, Hong Y, Liu Y and
Xue Y: MiR-320a down-regulation mediates bladder carcinoma invasion
by targeting ITGB3. Mol Biol Rep. 41:2521–2527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kumar M, Singh M and Singh SB:
Optimization of conditions for expression of recombinant
interferon-γ in E. coli. Mol Biol Rep. 41:6537–6543. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dahlrot RH: The prognostic value of
clinical factors and cancer stem cell-related markers in gliomas.
Dan Med J. 61:B49442014.PubMed/NCBI
|
|
14
|
Lim YC, Roberts TL, Day BW, Stringer BW,
Kozlov S, Fazry S, Bruce ZC, Ensbey KS, Walker DG, Boyd AW and
Lavin MF: Increased sensitivity to ionizing radiation by targeting
the homologous recombination pathway in glioma initiating cells.
Mol Oncol. 8:1603–1615. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fukai J, Koizumi F and Nakao N: Enhanced
anti-tumor effect of zoledronic acid combined with temozolomide
against human malignant glioma cell expressing O6-methylguanine DNA
methyltransferase. PLoS One. 9:e1045382014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang F, Zamora G, Sun CH, Trinidad A, Chun
C, Kwon YJ, Berg K, Madsen SJ and Hirschberg H: Increased
sensitivity of glioma cells to 5-fluorocytosine following
photo-chemical internalization enhanced nonviral transfection of
the cytosine deaminase suicide gene. J Neurooncol. 118:29–37. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen T, Wang XY, Li C and Xu SJ:
Downregulation of microRNA-124 predicts poor prognosis in glioma
patients. Neurol Sci. 36:131–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Shi ZM, Jiang CF, Liu X, Chen QD,
Qian X, Li DM, Ge X, Wang XF, Liu LZ, et al: MiR-143 acts as a
tumor suppressor by targeting N-RAS and enhances
temozolomide-inducedapoptosis in glioma. Oncotarget. 5:5416–27.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Y, Zhao J, Zhang PY, Zhang Y, Sun SY,
Yu SY and Xi QS: MicroRNA-10b targets E-cadherin and modulates
breast cancer metastasis. Med Sci Monit. 18:BR299–BR308. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lonjedo M, Poch E, Mocholí E,
Hernández-Sánchez M, Ivorra C, Franke TF, Guasch RM and Pérez-Roger
I: The Rho family member RhoE interacts with Skp2 and is degraded
at the proteasome during cell cycle progression. J Biol Chem.
288:30872–30882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang Y, Hu C, Yang H, Cao L, Li Y, Deng P
and Huang L: Rnd3 regulates lung cancer cell proliferation through
notch signaling. PLoS One. 9:e1118972014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Riento K, Guasch RM, Garg R, Jin B and
Ridley AJ: RhoE binds to ROCK I and inhibits downstream signaling.
Mol Cell Biol. 23:4219–4229. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma W, Wong CC, Tung EK, Wong CM and Ng IO:
RhoE is frequently down-regulated in hepatocellular carcinoma (HCC)
and suppresses HCC invasion through antagonizing the
Rho/Rho-kinase/myosin phosphatase target pathway. Hepatology.
57:152–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Poch E, Miñambres R, Mocholí E, Ivorra C,
Pérez-Aragó A, Guerri C, Pérez-Roger I and Guasch RM: RhoE
interferes with Rb inactivation and regulates the proliferation and
survival of the U87 human glioblastoma cell line. Exp Cell Res.
313:719–731. 2007. View Article : Google Scholar : PubMed/NCBI
|
